Most Recent
AstraZeneca has slammed Pharmacor's defence to claims it infringed a patent for blockbuster diabetes drug Forxiga as a "complete shot in the dark", as the drug maker unsuccessfully fought orders to produce documents from a UK case.
An Australian designer has sued e-commerce giant Shopify, alleging it failed to act when he complained about so-called 'ghost stores' that allegedly copied his designs on almost 4,000 occasions.
Hamilton Locke has brought on four new partners to boost its expertise in areas in high-demand among its clients.
A recent judgment that clarified the date for assessing best method knowledge for divisional patents appears to create new difficulties for patent applicants, lawyers say.
An employee of e-commerce merchandise importer New Aim wants the High Court to overturn a ruling that found he breached his duty of confidence by providing competitors with contact details of the company's suppliers, stored on WeChat on his personal phone.
A Sydney businessman has emerged victorious in a fight with DC Comics over his bid to register a 'kryptonite diet' logo as a trade mark.
Zip Co has reached an agreement to acquire the 'Zip' trade mark from non-bank lender Firstmac, after the High Court rejected its honest concurrent use defence last week.
The operator of Hunter Valley's luxury Elysia Retreat has settled its trade mark infringement suit against the newly established Elysium Hotel in Noosa.
Danish glassware brand Bodum has lost its intellectual propety suit against Maxwell & Williams, despite a court finding the homewares company's coffee glasses were a “conscious imitation” of Bodum's products.
Construction company Built has lost its opposition to an application by job recruitment platform Built In for registration of the trade marks 'Built in Australia' and 'Built in Sydney'.